Non-invasive prediction model of axillary lymph node status in patients with early-stage breast cancer: a feasibility study based on dynamic contrast-enhanced-MRI radiomics
View abstract on PubMed
Summary
This summary is machine-generated.This study developed a non-invasive radiomics model using dynamic contrast-enhanced MRI to accurately assess axillary lymph node status in early breast cancer patients, aiding personalized treatment.
Area Of Science
- Oncology
- Radiology
- Medical Imaging
Background
- Accurate axillary lymph node (ALN) evaluation is crucial for breast cancer prognosis and treatment planning.
- Current methods may be invasive or lack precision in preoperative staging.
Purpose Of The Study
- To develop and validate a dynamic contrast-enhanced MRI (DCE-MRI)-based radiomics model for preoperative ALN status evaluation in early-stage breast cancer.
- To assess the model's ability to predict ALN metastasis and burden.
Main Methods
- Retrospective analysis of 410 early-stage breast cancer patients.
- Radiomics features extracted from DCE-MRI images.
- Construction of a radiomics signature and a combined nomogram incorporating clinical predictors.
Main Results
- A radiomics signature comprising 14 features was developed.
- The nomogram, incorporating radiomics score and clinical factors, demonstrated strong performance in discriminating metastatic from non-metastatic ALNs (AUCs 0.859-0.881).
- The model accurately differentiated between high and low ALN metastatic burden.
Conclusions
- A DCE-MRI-based radiomics nomogram offers a potential non-invasive tool for accurate preoperative ALN burden assessment.
- This approach can assist in personalized axillary treatment strategies for early breast cancer.
- The developed model is non-invasive and user-friendly for preoperative evaluation.

